MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy® Hi·Art® treatment system for advanced radiation therapy, today announced the close of its Treatment Quality Challenge. The company had offered $250,000 to any U.S. cancer center that could surpass the quality of a helical TomoTherapySM treatment plan using a single-rotation Varian RapidArc™ plan delivered in two minutes or less. The three-month program ended on June 30, 2008, without a single entry.
